| 套细胞淋巴瘤诊治进展 |
| |
| 引用本文： | 陈格格(综述),施菊妹,张轶文(审校). 套细胞淋巴瘤诊治进展[J]. 白血病．淋巴瘤, 2016, 25(10): 637-640. DOI: 10.3760/cma.j.issn.1009-9921.2016.10.019 |
| |
| 作者姓名： | 陈格格(综述) 施菊妹 张轶文(审校) |
| |
| 作者单位： | 200070,上海市第十人民医院 同济大学附属第十人民医院血液科;200070,上海市第十人民医院 同济大学附属第十人民医院血液科;200070,上海市第十人民医院 同济大学附属第十人民医院血液科 |
| |
| 摘 要： | 套细胞淋巴瘤（MCL）是小 B 细胞淋巴瘤中一组高侵袭性的非霍奇金淋巴瘤（NHL），约占NHL 的6%。MCL 起病隐匿、侵袭性强、恶性程度高、预后差，因此，MCL 的诊断及鉴别诊断至关重要。另外，MCL 分子病理模型、细胞周期蛋白 D1阴性 MCL、MCL 分期预后及分层治疗选择均值得关注。
|
| 关 键 词： | 淋巴瘤 膜细胞 非霍奇金 诊断 治疗 |
Progress in diagnosis and treatment of mantle cell lymphoma |
| |
| Chen Gege,Shi Jumei,Zhang Yiwen. Progress in diagnosis and treatment of mantle cell lymphoma[J]. Journal of Leukemia & Lymphoma, 2016, 25(10): 637-640. DOI: 10.3760/cma.j.issn.1009-9921.2016.10.019 |
| |
| Authors: | Chen Gege Shi Jumei Zhang Yiwen |
| |
| Abstract: | Mantle cell lymphoma (MCL) is a group of highly aggressive non-Hodgkin lymphoma (NHL) in small B-cell lymphoma, accounting for 6 % of NHL incidence. MCL is characterized with its concealed onset, strong aggression, high malignancy and poor prognosis. Therefore, more attention should be paid to the diagnosis and differential diagnosis of MCL in clinic. Recently, diagnostic models of molecular pathology, researches on cyclin D1 protein negative MCL, staging prognosis and stratification treatment of MCL are worthy of attention. |
| |
| Keywords: | Lymphoma,mantle cell Lymphoma,non-Hodgkin Diagnosis Treatment |
| 本文献已被 万方数据 等数据库收录！ |
|
